Paper Details

  1. Home
  2. Paper Details

Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.

Author: AdetoroNikki A, BraunCarol J, HillierSharon L, MorganFranklin G, NyirjesyPaul, SchwebkeJane R, WaldbaumArthur S

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Oral secnidazole granules containing 1 and 2 g were superior to placebo in bacterial vaginosis treatment.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate secnidazole as a single oral dose treatment for bacterial vaginosis in a phase 2 randomized, double-blind, placebo-controlled study. METHODS: In a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study, women with bacterial vaginosis who met all Amsel crite...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/28697102

データ提供：米国国立医学図書館（NLM）

Secnidazole: A New Hope for Bacterial Vaginosis

The quest for [effective treatment of bacterial vaginosis (BV)] is a constant endeavor in [gynecology]. This research investigates the potential of [secnidazole], a single oral dose treatment, as a solution for this prevalent condition. The study aimed to evaluate the efficacy of secnidazole in treating BV, a condition that affects many women.

A Dose of Relief: Secnidazole Shows Promise

The results of this study are promising. The clinical cure rate for [2 g secnidazole] was [65.3%], significantly higher than the placebo group's [19.4%]. This signifies a substantial improvement in BV treatment outcomes with secnidazole. Both doses of secnidazole (1 g and 2 g) were well-tolerated, adding to the appeal of this potential treatment option.

A New Era of BV Treatment: Secnidazole Offers Hope

The findings suggest that secnidazole holds significant promise as an effective treatment for BV, offering women a potential new avenue for addressing this common condition. The success of this treatment could lead to better management of BV, improving women's health and overall well-being.

Dr.Camel's Conclusion

The journey to discover effective treatments for bacterial vaginosis is an ongoing one. This study sheds light on the potential of secnidazole as a promising new treatment option. Its effectiveness and safety are encouraging, offering a glimmer of hope for women seeking relief from this common condition.

Date :
  1. Date Completed 2017-08-21
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

28697102

DOI: Digital Object Identifier

00006250-201708000-00018

Related Literature

Article Analysis
・Effects of secnidazole
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.